Chia Tai Tianqing Pharmaceutical Group
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:China
|
| gptkbp:foundedYear |
1997
|
| gptkbp:headquartersLocation |
Nanjing, Jiangsu, China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chia Tai Tianqing Pharmaceutical Group
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Magnesium Isoglycyrrhizinate
Tianqing Ganmei Injection |
| gptkbp:numberOfEmployees |
over 5,000
|
| gptkbp:parentCompany |
China Grand Pharmaceutical and Healthcare Holdings
|
| gptkbp:products |
antibiotics
oncology drugs cardiovascular drugs hepatitis drugs |
| gptkbp:stockExchange |
Hong Kong Stock Exchange (via parent company)
|
| gptkbp:website |
http://www.cttq.com
|
| gptkbp:bfsParent |
gptkb:Anlotinib
|
| gptkbp:bfsLayer |
7
|